In accordance with the observations of samples from CML patients, no increased levels of Bcl-2 were observed in K562 cells, and a similar result was observed in its MDR sublines Lucena-1 and FEPS [39,68]. Here, BCL2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.